Mesalamine API Market Report

China Mesalamine API Industry Market Research Report 2023-2029

  • POSTDATE：Sep 11, 2023
  • PAGES：170
  • REPORT CODE：GMM1791571
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Mesalamine API industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • CTX Lifescience

    • Divis Laboratories

    • Wellona Pharma

    • Hema Pharmaceuticals

    • PharmaZell

    • LASA Supergenerics Ltd

    • Ipca Laboratories

    • Ishita Active Pharma Ingredients

    • Sun Pharma

    By Type:

    • Purity ≥ 98 %

    • Purity ≥ 99 %

    • Purity ≥ 97 %

    By Application:

    • Mesalamine Tablets

    • Others

    • Mesalamine Capsules

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Mesalamine API Market Overview 2018-2029

    • 1.1 China Mesalamine API Industry Development Overview

    • 1.2 China Mesalamine API Industry Development History

    • 1.3 China Mesalamine API Industry Market Size (2018-2029)

    • 1.4 China Mesalamine API Market Analysis by Type from Production Side

      • 1.4.1 China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 98 % (2018-2029)

      • 1.4.2 China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 99 % (2018-2029)

      • 1.4.3 China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 97 % (2018-2029)

    • 1.5 China Mesalamine API Market Analysis by Application from Consumption End

      • 1.5.1 China Mesalamine API Sales Volume, Sales Value and Growth Rate of Mesalamine Tablets (2018-2029)

      • 1.5.2 China Mesalamine API Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Mesalamine API Sales Volume, Sales Value and Growth Rate of Mesalamine Capsules (2018-2029)

    • 1.6 China Mesalamine API Market Analysis by Region

      • 1.6.1 North China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Mesalamine API Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Mesalamine API Market Size and Growth Rate from 2018-2029

    Chapter 2 China Mesalamine API Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Mesalamine API Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Mesalamine API Market Status and Competition Analysis in 2023

      • 2.2.3 China Mesalamine API Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Mesalamine API Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Mesalamine API Industry Development

    Chapter 3 Mesalamine APIIndustry Chain Analysis

    • 3.1 Mesalamine API Industry Chain

    • 3.2 Mesalamine API Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Mesalamine API Market

    • 3.3 Mesalamine API Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Mesalamine API Market

    Chapter 4 China Mesalamine API Market, by Type

    • 4.1 China Mesalamine API Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Mesalamine API Total Production Volume and Growth Rate from Production Side

    • 4.5 China Mesalamine API Production Volume and Growth Rate, by Type

      • 4.5.1 China Mesalamine API Production Volume and Growth Rate of Purity ≥ 98 %

      • 4.5.2 China Mesalamine API Production Volume and Growth Rate of Purity ≥ 99 %

      • 4.5.3 China Mesalamine API Production Volume and Growth Rate of Purity ≥ 97 %

    Chapter 5 China Mesalamine API Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Mesalamine API Total Market Size and Growth Rate from Consumption End

    • 5.5 China Mesalamine API Market Size and Growth Rate, by Application

      • 5.5.1 China Mesalamine API Market Size and Growth Rate of Mesalamine Tablets

      • 5.5.2 China Mesalamine API Market Size and Growth Rate of Others

      • 5.5.3 China Mesalamine API Market Size and Growth Rate of Mesalamine Capsules

    Chapter 6 China Mesalamine API Market, by Region

    • 6.1 China Mesalamine API Production Volume and Production Value, by Region

    • 6.2 China Mesalamine API Sales Volume and Sales Value, by Region

    Chapter 7 North China Mesalamine API Market Analysis

    • 7.1 North China Mesalamine API Market, by Type

    • 7.2 North China Mesalamine API Market, by Application

    Chapter 8 Central China Mesalamine API Market Analysis

    • 8.1 Central China Mesalamine API Market, by Type

    • 8.2 Central China Mesalamine API Market, by Application

    Chapter 9 South China Mesalamine API Market Analysis

    • 9.1 South China Mesalamine API Market, by Type

    • 9.2 South China Mesalamine API Market, by Application

    Chapter 10 East China Mesalamine API Market Analysis

    • 10.1 East China Mesalamine API Market, by Type

    • 10.2 East China Mesalamine API Market, by Application

    Chapter 11 Northeast China Mesalamine API Market Analysis

    • 11.1 Northeast China Mesalamine API Market, by Type

    • 11.2 Northeast China Mesalamine API Market, by Application

    Chapter 12 Southwest China Mesalamine API Market Analysis

    • 12.1 Southwest China Mesalamine API Market, by Type

    • 12.2 Southwest China Mesalamine API Market, by Application

    Chapter 13 Northwest China Mesalamine API Market Analysis

    • 13.1 Northwest China Mesalamine API Market, by Type

    • 13.2 Northwest China Mesalamine API Market, by Application

    Chapter 14 Company Profiles

      • 14.1 CTX Lifescience

        • 14.1.1 CTX Lifescience Company Profile

        • 14.1.2 CTX Lifescience Mesalamine API Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Divis Laboratories

        • 14.2.1 Divis Laboratories Company Profile

        • 14.2.2 Divis Laboratories Mesalamine API Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Wellona Pharma

        • 14.3.1 Wellona Pharma Company Profile

        • 14.3.2 Wellona Pharma Mesalamine API Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Hema Pharmaceuticals

        • 14.4.1 Hema Pharmaceuticals Company Profile

        • 14.4.2 Hema Pharmaceuticals Mesalamine API Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 PharmaZell

        • 14.5.1 PharmaZell Company Profile

        • 14.5.2 PharmaZell Mesalamine API Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 LASA Supergenerics Ltd

        • 14.6.1 LASA Supergenerics Ltd Company Profile

        • 14.6.2 LASA Supergenerics Ltd Mesalamine API Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Ipca Laboratories

        • 14.7.1 Ipca Laboratories Company Profile

        • 14.7.2 Ipca Laboratories Mesalamine API Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Ishita Active Pharma Ingredients

        • 14.8.1 Ishita Active Pharma Ingredients Company Profile

        • 14.8.2 Ishita Active Pharma Ingredients Mesalamine API Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sun Pharma

        • 14.9.1 Sun Pharma Company Profile

        • 14.9.2 Sun Pharma Mesalamine API Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Mesalamine API Industry Research Conclusions

    • 15.2 Mesalamine API Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Mesalamine API Industry Market Size (2018-2029)

    • Figure China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 98 % (2018-2029)

    • Figure China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 99 % (2018-2029)

    • Figure China Mesalamine API Production Volume, Production Value and Growth Rate of Purity ≥ 97 % (2018-2029)

    • Figure China Mesalamine API Sales Volume, Sales Value and Growth Rate of Mesalamine Tablets (2018-2029)

    • Figure China Mesalamine API Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Mesalamine API Sales Volume, Sales Value and Growth Rate of Mesalamine Capsules (2018-2029)

    • Figure North China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure Central China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure South China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure East China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Mesalamine API Market Size and Growth Rate from 2018-2029

    • Figure Mesalamine API Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Mesalamine API Market Share by Type in 2018

    • Figure China Mesalamine API Market Share by Type in 2023

    • Figure China Mesalamine API Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Mesalamine API Production Volume and Growth Rate of Purity ≥ 98 % (2018-2023)

    • Figure China Mesalamine API Production Volume and Growth Rate of Purity ≥ 99 % (2018-2023)

    • Figure China Mesalamine API Production Volume and Growth Rate of Purity ≥ 97 % (2018-2023)

    • Figure China Mesalamine API Market Share by Application in 2018

    • Figure China Mesalamine API Market Share by Application in 2023

    • Figure China Mesalamine API Total Market Size and Growth Rate from Consumption End

    • Figure China Mesalamine API Market Size and Growth Rate of Mesalamine Tablets (2018-2023)

    • Figure China Mesalamine API Market Size and Growth Rate of Others (2018-2023)

    • Figure China Mesalamine API Market Size and Growth Rate of Mesalamine Capsules (2018-2023)

    • Table China Mesalamine API Production Volume by Region (2018-2023)

    • Table China Mesalamine API Production Volume Share by Region (2018-2023)

    • Figure China Mesalamine API Production Volume Share by Region (2018-2023)

    • Table China Mesalamine API Production Value by Region (2018-2023)

    • Table China Mesalamine API Production Value Share by Region (2018-2023)

    • Figure China Mesalamine API Production Value Share by Region (2018-2023)

    • Table China Mesalamine API Sales Volume by Region (2018-2023)

    • Table China Mesalamine API Sales Volume Share by Region (2018-2023)

    • Figure China Mesalamine API Sales Volume Share by Region (2018-2023)

    • Table China Mesalamine API Sales Value by Region (2018-2023)

    • Table China Mesalamine API Sales Value Share by Region (2018-2023)

    • Figure China Mesalamine API Sales Value Share by Region (2018-2023)

    • Table North China Mesalamine API Production Volume by Type (2018-2023)

    • Table North China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure North China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table North China Mesalamine API Sales Volume by Application (2018-2023)

    • Table North China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure North China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table Central China Mesalamine API Production Volume by Type (2018-2023)

    • Table Central China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure Central China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table Central China Mesalamine API Sales Volume by Application (2018-2023)

    • Table Central China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure Central China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table South China Mesalamine API Production Volume by Type (2018-2023)

    • Table South China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure South China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table South China Mesalamine API Sales Volume by Application (2018-2023)

    • Table South China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure South China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table East China Mesalamine API Production Volume by Type (2018-2023)

    • Table East China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure East China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table East China Mesalamine API Sales Volume by Application (2018-2023)

    • Table East China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure East China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table Northeast China Mesalamine API Production Volume by Type (2018-2023)

    • Table Northeast China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure Northeast China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table Northeast China Mesalamine API Sales Volume by Application (2018-2023)

    • Table Northeast China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table Southwest China Mesalamine API Production Volume by Type (2018-2023)

    • Table Southwest China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure Southwest China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table Southwest China Mesalamine API Sales Volume by Application (2018-2023)

    • Table Southwest China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table Northwest China Mesalamine API Production Volume by Type (2018-2023)

    • Table Northwest China Mesalamine API Production Volume Share by Type (2018-2023)

    • Figure Northwest China Mesalamine API Production Volume Share by Type (2018-2023)

    • Table Northwest China Mesalamine API Sales Volume by Application (2018-2023)

    • Table Northwest China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Mesalamine API Sales Volume Share by Application (2018-2023)

    • Table CTX Lifescience Company Profile

    • Table CTX Lifescience Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Divis Laboratories Company Profile

    • Table Divis Laboratories Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Wellona Pharma Company Profile

    • Table Wellona Pharma Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Hema Pharmaceuticals Company Profile

    • Table Hema Pharmaceuticals Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table PharmaZell Company Profile

    • Table PharmaZell Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table LASA Supergenerics Ltd Company Profile

    • Table LASA Supergenerics Ltd Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Ipca Laboratories Company Profile

    • Table Ipca Laboratories Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Ishita Active Pharma Ingredients Company Profile

    • Table Ishita Active Pharma Ingredients Mesalamine API Revenue, Price and Gross (2018-2023)

    • Table Sun Pharma Company Profile

    • Table Sun Pharma Mesalamine API Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US